Status:
UNKNOWN
Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation
Lead Sponsor:
Medical University of Vienna
Conditions:
Osteoporosis
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with a terminal chronic liver disease have a disordered bone metabolism resulting in a higher risk of falling ill with osteoporosis. Although liver transplantation restores liver function, im...
Eligibility Criteria
Inclusion
- primary liver transplantation
- retransplantation within two weeks
- written informed consent
- Age ≥ 18 years
Exclusion
- chronic kidney disease:
- Creatinine Clearance \< 35 ml/min or Serum Creatinine \> 2,5 mg/dl
- known hypersensitivity to Zoledronate, or any of the recipients of the drug
- bone specific medication (Bisphosphonate, Fluoride, Calcitonin) within the last three months before liver transplantation
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00302484
Start Date
April 1 2002
Last Update
July 26 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna, Department of Surgery, Division of Transplantation
Vienna, Vienna, Austria, A-1090